Targeting cytokine- therapy to alleviate neuropathic pain caused by the spinal damage
DOI:
https://doi.org/10.36552/pjns.v28i1.969Keywords:
C – Spine injuriesReferences
Allison DJ, Thomas A, Beaudry K, Ditor DS. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. Journal of neuroinflammation. 2016;13:1-0.
Iwatsuki K, Arai T, Ota H, Kato S, Natsume T, Kurimoto S, Yamamoto M, Hirata H. Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain. PLoS One. 2013;8(2):e57721.
Park J, Decker JT, Smith DR, Cummings BJ, Anderson AJ, Shea LD. Reducing inflammation through delivery of lentivirus encoding for anti-inflammatory cytokines attenuates neuropathic pain after spinal cord injury. Journal of controlled release. 2018;290:88-101.
Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scandinavian journal of pain. 2017 Oct 1;17(1):287-93.
Chio JC, Xu KJ, Popovich P, David S, Fehlings MG. Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives. Experimental Neurology. 2021;341:113704.
Hagen EM, Rekand T. Management of neuropathic pain associated with spinal cord injury. Pain and therapy. 2015;4:51-65.
Roselli F, Chandrasekar A, Morganti-Kossmann MC. Interferons in traumatic brain and spinal cord injury: current evidence for translational application. Frontiers in neurology. 2018;9:388683.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Saman Shahid, Muhammad Anwar ChaudaryThe work published by PJNS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Copyrights on any open access article published by Pakistan Journal of Neurological Surgery are retained by the author(s).